OSCR
Get informed when a big investor buys or sells
+ FollowUndervalued by 122.2% based on the discounted cash flow analysis.
| Market cap | $7.36 Billion |
|---|---|
| Enterprise Value | $2.99 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1.69 |
| Beta | 2.39 |
| Outstanding Shares | 298,184,000 |
| P/E Ratio | -214.79 |
|---|---|
| PEG | -146.45 |
| Price to Sales | 0.65 |
| Price to Book Ratio | 5.73 |
| Enterprise Value to Revenue | 0.22 |
| Enterprise Value to EBIT | 174.08 |
| Enterprise Value to Net Income | -76 |
| Total Debt to Enterprise | 0.14 |
| Debt to Equity | 0.26 |
No data
Market sentiment based on institutional option activity.
| Put/Call Ratio | 1.0730▲ 7.50% |
|---|---|
| Total Calls | 11,243,700▼ 27.31% |
| Total Puts | 12,064,300▼ 21.85% |
Holdings and activity of institutional investors.
| Ownership % | 61.60%▼ 3.42% |
|---|---|
| Total Invested | $2.01B▼ 17.20% |
| Investors Holding | 364▼ 12.00% |
No data
Headquartered in New York City, Oscar has been challenging the health care s\stem's status quo since our founding in 2012. The compan\Ŗs member-ırst philosoph\ and innovative approach to care has earned us the trust of approxim...